Can ChatGPT be Counted On?

Chatbots and artificial intelligence are increasingly becoming more popular to answer questions about health. Researchers studied one of these resources, ChatGPT, to provide incredibly valuable and well-timed insights into the capabilities and limitations of artificial intelligence in the context of cancer-related information. Are people with cancer and their caregivers getting accurate answers?

Huntsman Cancer Institute Thoracic Surgeon Thomas K. Varghese Jr. MD, MS, MBA, FACS, Named President-Elect of Society of University Surgeons

One of the world’s premier associations dedicated to the advancement of surgical science elected Varghese as 2023-24 president-elect. Huntsman Cancer Institute’s chief value officer and associate chief medical quality officer will begin his one-year role in February 2024. “Scientific progress relies on problem solving and collaboration, where groups of people with diverse experiences and areas of expertise are empowered to lead, be creative, and innovate,” Varghese says.

Research Highlights for February 2023

Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see how a new clinical trial looks at less-invasive breast cancer treatments. Finally, find out how a new grant could help veterans get the cancer care they need.

Three Talented Researchers Recognized as Endowed Chairs

Huntsman Cancer Institute is proud to announce Brad Cairns, PhD, as the inaugural recipient of the Jon M. Huntsman Presidential Endowed Chair in Cancer Research given by the 2018 Utah State Legislature. In addition, Aik Choon Tan, PhD, was named the Jon and Karen Huntsman Presidential Professor in Cancer Research and Alana Welm, PhD, received a five-year extension as the Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research.

Huntsman Cancer Institute Research Highlights for January 2023

Each month, we’d like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done to prevent cancer risks in young adults, gain an understanding of how a specific DNA mutation can change lung cancer tumors, check out how nurses are creating a new way to monitor a serious type of pneumonia, and read how researchers have linked biomarkers to distress in colorectal cancer patients.

Kim Wirthlin to Lead Huntsman Cancer Foundation as President and COO

Generous donations make the remarkable growth and advancements in cancer care at Huntsman Cancer Institute possible. Huntsman Cancer Foundation, the nonprofit organization whose sole purpose is to raise funds to support the institute, has a new leader. Kim Wirthlin will be the president and chief operating officer (COO) beginning February 1. The foundation’s work is critical in supporting cutting-edge research and the highest standards of clinical care at Huntsman Cancer Institute.